Yale Podnos serves as Executive at Oncology Institute, Inc., where they oversee executive responsibilities. Since joining the company, Yale Podnos has executed 15 insider transactions totaling $404, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 17, 2025 involved receiving (via award) 2,086 shares valued at $0.
Yale Podnos currently holds 237,930 shares of Oncology Institute, Inc. (TOI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Yale Podnos has been a net seller of TOI stock. They have purchased $0 and sold $404 worth of shares.
Yale Podnos's most recent insider trade was on Nov 17, 2025, when they sold 2,086 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 12, 2025 | TOI | $0 | Award | 306 | $N/A | Discretionary |
| May 21, 2024 | TOI | $0 | Award | 17,530 | $N/A | Discretionary |
| Nov 21, 2023 | TOI | $3.4K | Disposition | 1,530 | $2.19 | Discretionary |
| Nov 14, 2023 | TOI | $4.4K | Disposition | 1,860 | $2.39 | Discretionary |
| Nov 14, 2023 | TOI | $569 | Disposition | 238 | $2.39 | Discretionary |
| Mar 17, 2023 | TOI | $0 | Award | 33,219 | $N/A | Discretionary |
| Nov 17, 2022 | TOI | $0 | Award | 14,164 | $N/A | Discretionary |
| Nov 15, 2022 | TOI | $404 | Disposition | 199 | $2.03 | Discretionary |
| Nov 15, 2022 | TOI | $404 | Sale | 199 | $2.03 | Discretionary |
| Mar 21, 2022 | TOI | $0 | Award | 12,720 | $N/A | Discretionary |
| Mar 21, 2022 | TOI | $0 | Award | 2,164 | $N/A | Discretionary |
| Nov 12, 2021 | TOI | $0 | Award | 11,359 | $N/A | Discretionary |
| Nov 12, 2021 | TOI | $0 | Award | 17,039 | $N/A | Discretionary |